SRC and neoplasm: SIRT2 could deacetylate IDH1 at K224 and exhibit a tumor suppression function in a colon cancer cell model by inhibiting IDH1 enzymatic activity and the hypoxia-inducible factor 1α (HIF1α)-SRC transcription axis.